Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Predictive Oncology Inc. Director's Dealing 2015

Jan 6, 2015

35106_dirs_2015-01-05_ba47592f-6135-416e-8d21-7e45623d6c37.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Skyline Medical Inc. (SKLN)
CIK: 0001446159
Period of Report: 2014-12-31

Reporting Person: MANCUSO FRANK G /FA/ (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-12-31 Stock Option (right to buy) $6.50 A 769 Acquired 2024-12-31 Common Stock (769) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, $.01 par value 4667 Direct

Footnotes

F1: Share ownership totals have been adjusted to reflect a 1 for 75 reverse stock split effected by the issuer on October 24, 2014.